Gel-Del Technologies, a St. Paul, Minnesota based biomedical device company announced that it has concluded clinical trials of CosmetaLife, a dermal filler injection that company officials say holds potential to be a more effective alternative to currently
Read More...
Read the complete post at http://www.medilexicon.com/medicalnews.php?newsid=116098